Matthew Stanton - 15 Jul 2023 Form 4 Insider Report for Generation Bio Co. (GBIO)

Signature
/s/ Benjamin Waters, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
15 Jul 2023
Net transactions value
-$11,090
Form type
4
Filing time
18 Jul 2023, 16:35:14 UTC
Previous filing
18 Apr 2023
Next filing
17 Oct 2023

Quoteable Key Fact

"Matthew Stanton filed Form 4 for Generation Bio Co. (GBIO) on 18 Jul 2023."

Quick Takeaways

  • This page summarizes Matthew Stanton's Form 4 filing for Generation Bio Co. (GBIO).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 18 Jul 2023, 16:35.

What Changed

  • Previous filing in this sequence was filed on 18 Apr 2023.
  • Current net transaction value: -$11,090.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

GBIO transaction

Common Stock

Options Exercise

Transaction value
Shares
+7,437
Change %
+3.3%
Price
Shares after
231,468
Date
15 Jul 2023
Ownership
Direct
Footnotes
F1
GBIO transaction

Common Stock

Tax liability

Transaction value
$11,090
Shares
-2,183
Change %
-0.94%
Price
$5.08
Shares after
229,285
Date
15 Jul 2023
Ownership
Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

GBIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-7,437
Change %
-33%
Price
$0.000000
Shares after
14,874
Date
15 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,437
Exercise price
Footnotes
F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .